制药工业
制药工业
过程(计算)
药物开发
药物发现
科学发现
新产品开发
业务
数据科学
纳米技术
工程伦理学
工程类
管理科学
药品
计算机科学
生物技术
医学
营销
心理学
药理学
生物
生物信息学
认知科学
材料科学
操作系统
作者
Sheo B. Singh,Gary E. Martin,Brian McKittrick,Jonathan Crowther,Howard Fraenkel,Charles A. Lunn,M L Bayne,John B. Perkins,Vincent P. Gullo
标识
DOI:10.1021/acs.jnatprod.4c00081
摘要
Research collaborations and licensing deals are critical for the discovery and development of life-saving drugs. This practice has been ongoing since the inception of the pharmaceutical industry. The current process of drug discovery and development is complex, regulated, and highly regimented, having evolved over time. Academia excels in the discovery of fundamental scientific concepts and biological processes, while industry excels in translational science and product development. Potential for collaboration exists at every step of the drug discovery and development continuum. This perspective walks through such collaborative activities, provides examples, and offers tips for potential collaborations.
科研通智能强力驱动
Strongly Powered by AbleSci AI